On drug treatment and social control: Russian narcology's great leap backwards

The medical discipline of narcology in Russia is a subspecialty of psychiatry from the Soviet era and it is given warrant to define the scope of health activities with regard to alcohol and other drug use, drug users, and related problems. Narcological practice is in turn constrained by the State. The emergence of widespread injection opiate use and associated HIV morbidities and mortalities during the first decade following the collapse of the Soviet Union has brought the contradictions in Russian narcological discourse into high relief. Narcology officials in the Russian Federation have consistently opposed substitution treatment for opiate dependence – the replacement of a short-acting illegal substance with a longer acting prescribed drug with similar pharmacological action but lower degree of risk. Thus, despite the addition of methadone and buprenorphine to WHO's list of essential medicines in 2005 and multiple position papers by international experts calling for substitution treatment as a critical element in the response to HIV (IOM, 2006; UNODC, UNAIDS, and WHO, 2005), methadone or buprenorphine remain prohibited by law in Russia

Origin of the 871-keV gamma ray and the ``oxide'' attribute

This work concludes the investigation of the oxide attribute of current interest for the characterization of stored plutonium. Originally it was believed that the presence of oxide could be ascertained by measurement of the 871-keV line in a high-resolution gamma-ray spectrum. However, recent work has suggested that the 871-keV gamma ray in plutonium oxide arises from the reaction {sup 14}N({alpha},p){sup 17}O rather than the inelastic scattering reaction {sup 17}O({alpha},{alpha}{prime}){sup 17}O*. This conclusion, though initially surprising, was obtained during efforts to determine the relative importance of americium and plutonium alpha-particle decay for the production of the 871-keV gamma ray. Several questions were raised by previous experiments: What role, if any does {sup 17}O have in the generation of the 871-keV gamma ray? How does sufficient nitrogen come to be present in plutonium oxide? Under what conditions is the 871-keV gamma ray measurable in plutonium oxide? This paper describes the answers to these questions